Interneuron Pharmaceuticals Inc. has raised $7 million throughthe redemption of its 3.18 million class A warrants outstanding.Following the exercise, the Lexington, Mass., developer ofproducts to treat neurological and behavioral disorders(NASDAQ:IPIC) has 21 million shares outstanding.

(c) 1997 American Health Consultants. All rights reserved.